Acture Denmark A/S: Financial statements 2022
CVR: 30273893
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Acture Denmark A/S (CVR 30273893) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 16,574,679 and a net result of DKK 3,620,901 compared with DKK 3,677,962 the year before. That is an increase of 2% compared with the year before. Equity in the 2022 report amounted to DKK 9,064,568. The solvency ratio was 69.6%. The company had 17 employees in the financial year.
- Gross Profit
- DKK 16,574,679
- Profit/Loss
- DKK 3,620,901
- Equity
- DKK 9,064,568
- Total Assets
- DKK 13,018,313
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 16.6 mio. | 3.6 mio. | 9.1 mio. | 17 |
| 2021 | - | 16.3 mio. | 3.7 mio. | 7.4 mio. | 16 |
| 2020 | - | 12.8 mio. | 2.6 mio. | 5.8 mio. | 13 |
| 2019 | - | 12.3 mio. | 1.3 mio. | 4.2 mio. | 15 |
| 2018 | - | 8.6 mio. | 159 t. | 3.4 mio. | 12 |
Official annual report
Keep an eye on Acture Denmark A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Acture Denmark A/S has published its annual report for 2021. Gross profit came to DKK 16,253,505, and the net result was DKK 3,677,962.
About Acture Denmark A/S
Acture Denmark A/S is a Danish company of the type Aktieselskab based in Holte, founded in 2007. The company is registered under the industry Fysio- og ergoterapi. The company was previously named HEALTH GROUP A/S and HEALTHGROUP A/S. The management consists of Adam Rosenkilde. The board consists of Maudie Derks (chair), Humphrey Saffeer Perdaems and Adam Rosenkilde. The company is owned by Acture Group B.V.. The company has 93 employees (2026). In 2025, the company reported a gross profit of DKK 22,212,804 and a net result of DKK 4,526,756 compared with DKK 3,488,947 the year before. Equity in the 2025 report amounted to DKK 8,549,047.
